Proteon Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Proteon Pharmaceuticals's estimated annual revenue is currently $9.1M per year.
- Proteon Pharmaceuticals's estimated revenue per employee is $77,500
- Proteon Pharmaceuticals has 118 Employees.
- Proteon Pharmaceuticals grew their employee count by -5% last year.
Proteon Pharmaceuticals Competitors & AlternativesAdd Company
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Proteon Pharmaceuticals?
Proteon Pharmaceuticals SA is an innovative biotech company using bacteriophages as the foundation for preventing and eradicating bacterial diseases in food animals, humans and plants. Bacteriophages are naturally existing organisms occurring in the microbiome.keywords:N/A
Number of Employees
Employee Growth %
Proteon Pharmaceuticals News
For years, pharmaceutical companies have tried to keep pace with ... Polish startup Proteon Pharmaceuticals are among the first to make...
To produce antibacterial solution for livestock by 2023 and tap neighbouring countries. Poland-based Proteon Pharmaceuticals (India) plans to...
The major key players are - NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences...
Animal health giant Nutreco and aquaculture-focused VC firm Aqua-Spark have co-led a €21 million ($24.6 million) investment into Proteon Pharmaceuticals – a Polish startup which is aiming to reduce animal agriculture’s reliance on antibiotics and slow down rising resistance to antimicrobial drug ...
Zacks Investment Research cut Proteon Therapeutics from a “buy” rating to a ... focuses on the development of pharmaceuticals to address the ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|